Currently out of the existing stock ratings of Michael Nedelcovych, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).

Michael Nedelcovych

Work Performance Price Targets & Ratings Chart

Analyst Michael Nedelcovych, currently employed at TD COWEN, has had 68.06% of price targets met with an average potential upside of 14.58%, reached in 189 days on average.

Michael Nedelcovych has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on JNJ, Johnson & Johnson at 13-Jul-2026.

Wall Street Analyst Michael Nedelcovych

Analyst best performing recommendations are on TAK (TAKEDA PHARMACEUTICAL CO LTD ADR).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) on 12/12/2022. The price target of $72.5 was fulfilled within 109 days with a profit of $13.75 (23.4%), with a performance score of 2.15.

Average potential price target upside

NVO Novo Nordisk A/S TAK Takeda Pharmaceutical Co Ltd ADR JNJ Johnson & Johnson RPRX Royalty Pharma Plc

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-May-2025

$40

$-1.63 (-3.92%)

$47

1 months 5 days ago
(12-Oct-2026)

13/26 (50%)

$1.36 (3.52%)

29

Hold Since 11-Sep-2026

$40

$-1.63 (-3.92%)

$40

2 months 6 days ago
(11-Sep-2026)

4/4 (100%)

$-3.07 (-7.13%)

32

Buy Since 20-Nov-2025

$62

5 months ago
(17-Jun-2026)

1/2 (50%)

$15.28 (32.71%)

210

Hold Since 03-Jun-2026

$47

$5.37 (12.90%)

$41

5 months 14 days ago
(03-Jun-2026)

3/6 (50%)

$5.53 (13.33%)

41

Buy Since 07-Jun-2022

8 months 24 days ago
(24-Feb-2026)

10/10 (100%)

$32.06 (35.10%)

255

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Nedelcovych most bullish on?

Potential upside of $14.25 has been obtained for JNJ (JOHNSON & JOHNSON)

What Year was the first public recommendation made by Michael Nedelcovych?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?